Targeting polyamine metabolism for cancer therapy and prevention

Biochemical Journal

Volumn 473, Issue 19, 2016, Pages 2937-2953

  Tracy, R Murray Stewart ^a   Woster, Patrick M ^b   Casero, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSYLMETHIONINE DECARBOXYLASE; ANTINEOPLASTIC AGENT; EFLORNITHINE; ENZYME INHIBITOR; ORNITHINE DECARBOXYLASE; OXIDOREDUCTASE; POLYAMINE; POLYAMINE BIOSYNTHESIS INHIBITOR; POLYAMINE DERIVATIVE; SPERMIDINE; SPERMIDINE INHIBITOR; SPERMINE OXIDASE; SPERMINE SYNTHASE; SPERMINE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

CANCER PREVENTION; CARCINOGENESIS; CATABOLISM; DRUG TARGETING; ENZYME INHIBITION; HUMAN; MALIGNANT NEOPLASM; MOLECULARLY TARGETED THERAPY; NONHUMAN; POLYAMINE METABOLISM; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; REVIEW; COMBINATION DRUG THERAPY; METABOLISM; NEOPLASMS; TRANSPORT AT THE CELLULAR LEVEL;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; DRUG THERAPY, COMBINATION; HUMANS; NEOPLASMS; POLYAMINES;

EID: 85010001972     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BCJ20160383     Document Type: Review

References (150)

1. Pasini, A., Caldarera, C.M. and Giordano, E. (2014) Chromatin remodeling by polyamines and polyamine analogs. Amino Acids 46, 595-603 doi:10.1007/s00726-013-1550-9.
2. Williams, K. (1997) Interactions of polyamines with ion channels. Biochem. J. 325(Pt 2), 289-297 doi:10.1042/bj3250289.
3. Baronas, V.A. and Kurata, H.T. (2014) Inward rectifiers and their regulation by endogenous polyamines. Front. Physiol. 5, 325 doi:10.3389/fphys.2014.00325.
4. Casero Jr, R.A. and Marton, L.J. (2007) Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat. Rev. Drug. Discov. 6, 373-390 doi:10.1038/nrd2243.
5. Pegg, A.E. (2009) Mammalian polyamine metabolism and function. IUBMB Life 61, 880-894 doi:10.1002/iub.230.
6. Lentini, A., Abbruzzese, A., Caraglia, M., Marra, M. and Beninati, S. (2004) Protein-polyamine conjugation by transglutaminase in cancer cell differentiation: Review article. Amino Acids 26, 331-337 doi:10.1007/s00726-004-0079-3.
7. Park, M.H., Nishimura, K., Zanelli, C.F. and Valentini, S.R. (2010) Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids 38, 491-500 doi:10.1007/s00726-009-0408-7.
8. Ha, H.C., Sirisoma, N.S., Kuppusamy, P., Zweier, J.L., Woster, P.M. and Casero Jr, R.A. (1998) The natural polyamine spermine functions directly as a free radical scavenger. Proc. Natl Acad. Sci. USA 95, 11140-11145 doi:10.1073/pnas.95.19.11140.
9. Ha, H.C., Yager, J.D., Woster, P.A. and Casero Jr, R.A. (1998) Structural specificity of polyamines and polyamine analogues in the protection of DNA from strand breaks induced by reactive oxygen species. Biochem. Biophys. Res. Commun. 244, 298-303 doi:10.1006/bbrc.1998.8258.
10. Nakajima, K.-I., Zhu, K., Sun, Y.-H., Hegyi, B., Zeng, Q., Murphy, C.J. et al. (2015) KCNJ15/Kir4.2 couples with polyamines to sense weak extracellular electric fields in galvanotaxis. Nat. Commun. 6, 8532doi:10.1038/ncomms9532.
11. Russell, D.H. and Snyder, S.H. (1969) Amine synthesis in regenerating rat liver: Extremely rapid turnover of ornithine decarboxylase. Mol. Pharmacol. 5, 253-262 PMID:5783961.
12. Pegg, A.E. and Williams-Ashman, H.G. (1968) Rapid effects of testosterone in prostatic polyamine-synthesizing enzyme systems. Biochem. J. 109, 32P-33P doi:10.1042/bj1090032Pb.
13. Pegg, A.E. (2006) Regulation of ornithine decarboxylase. J. Biol. Chem. 281, 14529-14532 doi:10.1074/jbc.R500031200.
14. Coffino, P. (2001) Regulation of cellular polyamines by antizyme. Nat. Rev. Mol. Cell Biol. 2, 188-194 doi:10.1038/35056508.
15. Hayashi, S. (1995) Antizyme-dependent degradation of ornithine decarboxylase. Essays Biochem. 30, 37-47 PMID:8822147.
16. Kahana, C. (2009) Antizyme and antizyme inhibitor, a regulatory tango. Cell. Mol. Life. Sci. 66, 2479-2488 doi:10.1007/s00018-009-0033-3.
17. Bello-Fernandez, C., Packham, G. and Cleveland, J.L. (1993) The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl Acad. Sci. USA 90, 7804-7808. doi:10.1073/pnas.90.16.7804.
18. Wagner, A.J., Meyers, C., Laimins, L.A. and Hay, N. (1993) c-Myc induces the expression and activity of ornithine decarboxylase. Cell. Growth Differ. 4, 879-883 PMID:8297793.
19. Pegg, A.E. (2009) S-Adenosylmethionine decarboxylase. Essays Biochem. 46, 25-46 doi:10.1042/bse0460003.
20. Wahlfors, J., Alhonen, L., Kauppinen, L., Hyvönen, T., Jänne, J. and Eloranta, T.O. (1990) Human spermidine synthase: cloning and primary structure. DNA Cell Biol. 9, 103-110 doi:10.1089/dna.1990.9.103.
21. Korhonen, V.-P., Halmekytö, M., Kauppinen, L., Myöhänen, S., Wahlfors, J., Keinänen, T. et al. (1995) Molecular cloning of a cDNA encoding human spermine synthase. DNA Cell Biol. 14, 841-847 doi:10.1089/dna.1995.14.841.
22. Ikeguchi, Y., Bewley, M.C. and Pegg, A.E. (2006) Aminopropyltransferases: function, structure and genetics. J. Biochem. 139, 1-9 doi:10.1093/jb/mvj019.
23. Della Ragione, F., Russo, G., Oliva, A., Mastropietro, S., Mancini, A., Borrelli, A. et al. (1995) 50-Deoxy-50-methylthioadenosine phosphorylase and p16INK4 deficiency in multiple tumor cell lines. Oncogene 10, 827-833 PMID:7898924.
24. Casero, R.A. and Pegg, A.E. (2009) Polyamine catabolism and disease. Biochem. J. 421, 323-338 doi:10.1042/BJ20090598.
25. Casero Jr, R.A. and Pegg, A.E. (1993) Spermidine/spermine N1-Acetyltransferase-The turning point in polyamine metabolism. FASEB J. 7, 653-661 PMID:8500690.
26. Wu, T., Yankovskaya, V. and McIntire, W.S. (2003) Cloning, sequencing, and heterologous expression of the murine peroxisomal flavoprotein, N1-Acetylated polyamine oxidase. J. Biol. Chem. 278, 20514-20525 doi:10.1074/jbc.M302149200.
27. Wallace, H.M., Duthie, J., Evans, D.M., Lamond, S., Nicoll, K.M. and Heys, S.D. (2000) Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin. Cancer Res. 6, 3657-3661 PMID:10999758.
28. Wang, Y., Devereux, W., Woster, P., Stewart, T., Hacker, A. and Casero Jr, R. (2001) Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res. 61, 5370-5373 PMID:11454677.
29. Wang, Y., Hacker, A., Murray-Stewart, T., Fleischer, J.G., Woster, P.M. and Casero Jr, R.A. (2005) Induction of human spermine oxidase SMO(PAOh1) is regulated at the levels of new mRNA synthesis, mRNA stabilization and newly synthesized protein. Biochem. J. 386, 543-547 doi:10.1042/BJ20041084.
30. Murray-Stewart, T., Wang, Y., Goodwin, A., Hacker, A., Meeker, A. and Casero Jr, R.A. (2008) Nuclear localization of human spermine oxidase isoforms -possible implications in drug response and disease etiology. FEBS J. 275, 2795-2806 doi:10.1111/j.1742-4658.2008.06419.x.
31. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J., Cole, P.A. et al. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953 doi:10.1016/j.cell.2004.12.012.
32. Poulin, R., Casero, R.A. and Soulet, D. (2012) Recent advances in the molecular biology of metazoan polyamine transport. Amino Acids 42, 711-723 doi:10.1007/s00726-011-0987-y.
33. Soulet, D., Gagnon, B., Rivest, S., Audette, M. and Poulin, R. (2004) A fluorescent probe of polyamine transport accumulates into intracellular acidic vesicles via a two-step mechanism. J. Biol. Chem. 279, 49355-49366 doi:10.1074/jbc.M401287200.
34. Belting, M., Mani, K., Jonsson, M., Cheng, F., Sandgren, S., Jonsson, S. et al. (2003) Glypican-1 is a vehicle for polyamine uptake in mammalian cells: A pivital role for nitrosothiol-derived nitric oxide. J. Biol. Chem. 278, 47181-47189 doi:10.1074/jbc.M308325200.
35. Uemura, T., Stringer, D.E., Blohm-Mangone, K.A. and Gerner, E.W. (2010) Polyamine transport is mediated by both endocytic and solute carrier transport mechanisms in the gastrointestinal tract. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G517-G522 doi:10.1152/ajpgi.00169.2010.
36. Metcalf, B.W., Bey, P., Danzin, C., Jung, M.J., Casara, P. and Vevert, J.P. (1978) Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C4.1.1.17) by substrate and product analogues. J. Am. Chem. Soc. 100, 2551-2553 doi:10.1021/ja00476a050.
37. Seidenfeld, J. (1985) Effects of difluoromethylornithine on proliferation, polyamine content and plating efficiency of cultured human carcinoma cells. Cancer Chemother. Pharmacol. 15, 196-202 doi:10.1007/BF00263885.
38. Porter, C.W. and Bergeron, R.J. (1983) Spermidine requirement for cell proliferation in eukaryotic cells: structural specificity and quantitation. Science 219, 1083-1085 doi:10.1126/science.6823570.
39. Luk, G.D., Civin, C.I., Weissman, R.M. and Baylin, S.B. (1982) Ornithine decarboxylase: Essential in proliferation but not differentiation of human promyelocytic leukemia cells. Science 216, 75-77 doi:10.1126/science.6950518.
40. Luk, G.D., Goodwin, G., Gazdar, A.F. and Baylin, S.B. (1982) Growth-inhibitory effects of DL-Alpha-difluoromethylornithine in the spectrum of human lung carcinoma cells in culture. Cancer Res. 42, 3070-3073 PMID:6807536.
41. Abeloff, M.D., Rosen, S.T., Luk, G.D., Baylin, S.B., Zeltzman, M. and Sjoerdsma, A. (1986) Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer. Cancer Treat. Rep. 70, 843-845 PMID:3013400.
42. Abeloff, M.D., Slavik, M., Luk, G.D., Griffin, C.A., Hermann, J., Blanc, O. et al. (1984) Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine-An inhibitor of polyamine biosynthesis. J. Clin. Oncol. 2, 124-130 PMID:6422008.
43. Horn, Y., Schechter, P.J. and Marton, L.J. (1987) Phase I-II clinical trial with alpha-difluoromethylornithine-An inhibitor of polyamine biosynthesis. Eur. J. Cancer Clin. Oncol. 23, 1103-1107 doi:10.1016/0277-5379(87)90141-6.
44. Meyskens, F.L., Kingsley, E.M., Glattke, T., Loescher, L. and Booth, A. (1986) A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma. Invest. New Drugs. 4, 257-262 doi:10.1007/BF00179593.
45. Bassiri, H., Benavides, A., Haber, M., Gilmour, S.K., Norris, M.D. and Hogarty, M.D. (2015) Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma. Transl. Pediatr. 4, 226-238 doi:10.3978/j.issn.2224-4336.2015.04.06.
46. Koomoa, D.-L., Yco, L.P., Borsics, T., Wallick, C.J. and Bachmann, A.S. (2008) Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma. Cancer Res. 68, 9825-9831 doi:10.1158/0008-5472.CAN-08-1865.
47. Hogarty, M.D., Norris, M.D., Davis, K., Liu, X., Evageliou, N.F., Hayes, C.S. et al. (2008) ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma. Cancer Res. 68, 9735-9745 doi:10.1158/0008-5472.CAN-07-6866.
48. Wallick, C.J., Gamper, I., Thorne, M., Feith, D.J., Takasaki, K.Y., Wilson, S.M. et al. (2005) Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-Amplified human neuroblastoma cells. Oncogene 24, 5606-5618 doi:10.1038/sj.onc.1208808.
49. Williams-Ashman, H.G. and Schenone, A. (1972) Methyl glyoxal bis(guanylhydrazone) as a potent inhibitor of mammalian and yeast S-Adenosylmethionine decarboxylases. Biochem. Biophys. Res. Commun. 46, 288-295 doi:10.1016/0006-291X(72)90661-4.
50. Pleshkewych, A., Kramer, D.L., Kelly, E. and Porter, C.W. (1980) Independence of drug action on mitochondria and polyamines in L1210 leukemia cells treated with methylglyoxal-bis(guanylhydrazone). Cancer Res. 40, 4533-4540 PMID:7438087.
51. Regenass, U., Caravatti, G., Mett, H., Stanek, J., Schneider, P., Muller, M. et al. (1992) New S-Adenosylmethionine decarboxylase inhibitors with potent antitumor activity. Cancer Res. 52, 4712-4718 PMID:1511437.
52. Regenass, U., Mett, H., Stanek, J., Mueller, M., Kramer, D. and Porter, C.W. (1994) CGP 48664, a new S-Adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. Cancer Res. 54, 3210-3217 PMID:8205541.
53. Siu, L.L., Rowinsky, E.K., Hammond, L.A., Weiss, G.R., Hidalgo, M., Clark, G.M. et al. (2002) A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-Times-five every-Three-week schedule in patients with advanced solid malignancies. Clin. Cancer Res. 8, 2157-2166 PMID:12114416.
54. Pless, M., Belhadj, K., Menssen, H.D., Kern, W., Coiffier, B., Wolf, J. et al. (2004) Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: Results from a phase II multicenter study. Clin. Cancer Res. 10, 1299-1305 doi:10.1158/1078-0432.CCR-0977-03.
55. Tang, K.C., Pegg, A.E. and Coward, J.K. (1980) Specific and potent inhibition of spermidine synthase by the transition-state analog, S-Adenosyl-3-Thio-1, 8-diaminooctane. Biochem. Biophys. Res. Commun. 96, 1371-1377 doi:10.1016/0006-291X(80)90102-3.
56. Woster, P.M., Black, A.Y., Duff, K.J., Coward, J.K. and Pegg, A.E. (1989) Synthesis and biological evaluation of S-Adenosyl-1, 12-diamino-3-Thio-9-Azadodecane, a multisubstrate adduct inhibitor of spermine synthase. J. Med. Chem. 32, 1300-1307 doi:10.1021/jm00126a026.
57. Burns, M.R., Graminski, G.F., Weeks, R.S., Chen, Y. and O'Brien, T.G. (2009) Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor. J. Med. Chem. 52, 1983-1993 doi:10.1021/jm801580w.
58. Samal, K., Zhao, P., Kendzicky, A., Yco, L.P., McClung, H., Gerner, E. et al. (2013) AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport. Int. J. Cancer 133, 1323-1333 doi:10.1002/ijc.28139.
59. Hayes, C.S., Shicora, A.C., Keough, M.P., Snook, A.E., Burns, M.R. and Gilmour, S.K. (2014) Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment. Cancer Immunol. Res. 2, 274-285 doi:10.1158/2326-6066.CIR-13-0120-T.
60. Muth, A., Madan, M., Archer, J.J., Ocampo, N., Rodriguez, L. and Phanstiel, O. (2014) Polyamine transport inhibitors: design, synthesis, and combination therapies with difluoromethylornithine. J. Med. Chem. 57, 348-363 doi:10.1021/jm401174a.
61. Grossi, M., Phanstiel, O., Rippe, C., Swärd, K., Alajbegovic, A., Albinsson, S. et al. (2016) Inhibition of polyamine uptake potentiates the anti-proliferative effect of polyamine synthesis inhibition and preserves the contractile phenotype of vascular smooth muscle cells. J. Cell. Physiol. 231, 1334-1342 doi:10.1002/jcp.25236.
62. Levin, V.A., Uhm, J.H., Jaeckle, K.A., Choucair, A., Flynn, P.J., Yung, W.K.A. et al. (2000) Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N0-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Clin. Cancer Res. 6, 3878-3884 PMID:11051233.
63. Saulnier Sholler, G.L., Gerner, E.W., Bergendahl, G., MacArthur, R.B., VanderWerff, A., Ashikaga, T. et al. (2015) A phase I trial of DFMO targeting polyamine addiction in patients with relapsed/refractory neuroblastoma. PLoS ONE 10, e0127246 doi:10.1371/journal.pone.0127246.
64. Alexiou, G.A., Tsamis, K.I., Vartholomatos, E., Peponi, E., Tzima, E., Tasiou, I. et al. (2015) Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells. J. Neurooncol. 123, 217-224 doi:10.1007/s11060-015-1799-9.
65. Wallace, H.M. and Fraser, A.V. (2003) Polyamine analogues as anticancer drugs. Biochem. Soc. Trans. 31, 393-396 doi:10.1042/bst0310393.
66. Wallace, H.M., Fraser, A.V. and Hughes, A. (2003) A perspective of polyamine metabolism. Biochem. J. 376, 1-14 doi:10.1042/bj20031327.
67. Wallace, H.M. and Niiranen, K. (2007) Polyamine analogues-An update. Amino Acids 33, 261-265 doi:10.1007/s00726-007-0534-z.
68. Casero Jr, R.A. and Woster, P.M. (2009) Recent advances in the development of polyamine analogues as antitumor agents. J. Med. Chem. 52, 4551-4573 doi:10.1021/jm900187v.
69. Phanstiel, O. and Archer, J.J. (2012) Design of Polyamine Transport Inhibiotrs as Therapeutics, RSC Publishing, Cambridge, U.K.
70. Porter, C.W. and Bergeron, R.J. (1988) Enzyme regulation as an approach to interference with polyamine biosynthesis-An alternative to enzyme inhibition. Adv. Enzyme Regul. 27, 43-55 doi:10.1016/0065-2571(88)90009-X.
71. Porter, C.W. and Bergeron, R.J. (1988) Regulation of polyamine biosynthetic activity by spermidine and spermine analogs-A novel antiproliferative strategy. Adv. Exp. Med. Biol. 250, 677-690 doi:10.1007/978-1-4684-5637-0-60.
72. Porter, C.W., Bergeron, R.J. and Stolowich, N.J. (1982) Biological properties of N4-spermidine derivatives and their potential in anticancer chemotherapy. Cancer Res. 42, 4072-4078 PMID:7105005.
73. Porter, C.W., McManis, J., Casero, R.A. and Bergeron, R.J. (1987) Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth. Cancer Res. 47, 2821-2825 PMID:3567905.
74. Bernacki, R.J., Bergeron, R.J. and Porter, C.W. (1992) Antitumor activity of N, N0-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts. Cancer Res. 52, 2424-2430 PMID:1568212.
75. Casero Jr, R.A., Celano, P., Ervin, S.J., Porter, C.W., Bergeron, R.J. and Libby, P.R. (1989) Differential induction of spermidine/spermine N1-Acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res. 49, 3829-3833 PMID:2544259.
76. Casero Jr, R.A., Mank, A.R., Xiao, L., Smith, J., Bergeron, R.J. and Celano, P. (1992) Steady-state messenger RNA and activity correlates with sensitivity to N1, N12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer. Cancer Res. 52, 5359-5363 PMID:1327507.
77. Porter, C.W., Ganis, B., Libby, P.R. and Bergeron, R.J. (1991) Correlations between polyamine analogue-induced increases in spermidine/spermine N1-Acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res. 51, 3715-3720 PMID:2065327.
78. Devereux, W., Wang, Y., Stewart, T.M., Hacker, A., Smith, R., Frydman, B. et al. (2003) Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells. Cancer Chemother. Pharmacol. 52, 383-390 doi:10.1007/s00280-003-0662-4.
79. 2 in polyamine analogue-Treated human breast cancer cell lines. J. Biol. Chem. 280, 39843-39851 doi:10.1074/jbc.M508177200.
80. Pledgie-Tracy, A., Billam, M., Hacker, A., Sobolewski, M.D., Woster, P.M., Zhang, Z. et al. (2010) The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines. Cancer Chemother. Pharmacol. 65, 1067-1081 doi:10.1007/s00280-009-1112-8.
81. Creaven, P.J., Perez, R., Pendyala, L., Meropol, N.J., Loewen, G., Levine, E. et al. (1997) Unusual central nervous system toxicity in a phase I study of N1, N11 diethylnorspermine in patients with advanced malignancy. Invest. New Drugs 15, 227-234 doi:10.1023/A:1005827231849.
82. Hahm, H.A., Ettinger, D.S., Bowling, K., Hoker, B., Chen, T.L., Zabelina, Y. et al. (2002) Phase I study of N1, N11-diethylnorspermine in patients with non-small cell lung cancer. Clin. Cancer Res. 8, 684-690 PMID:11895896.
83. Streiff, R.R. and Bender, J.F. (2001) Phase 1 study of N1, N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignancies. Invest. New Drug. 19, 29-39 doi:10.1023/A:1006448516938.
84. Wolff, A.C., Armstrong, D.K., Fetting, J.H., Carducci, M.K., Riley, C.D., Bender, J.F. et al. (2003) A phase II study of the polyamine analog N1, N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer. Clin. Cancer Res. 9, 5922-5928 PMID:14676116.
85. Casero Jr, R.A., Mank, A.R., Saab, N.H., Wu, R., Dyer, W.J. and Woster, P.M. (1995) Growth and biochemical effects of unsymmetrically substituted polyamine analogues in human lung tumor cells 1. Cancer Chemother. Pharmacol. 36, 69-74 doi:10.1007/BF00685735.
86. Saab, N.H., West, E.E., Bieszk, N.C., Preuss, C.V., Mank, A.R., Casero Jr, R.A. et al. (1993) Synthesis and evaluation of unsymmetrically substituted polyamine analogues as modulators of human spermidine/spermine-N1-Acetyltransferase (SSAT) and as potential antitumor agents. J. Med. Chem. 36, 2998-3004 doi:10.1021/jm00072a020.
87. Hacker, A., Marton, L.J., Sobolewski, M. and Casero Jr, R.A. (2008) In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells. Cancer Chemother. Pharmacol. 63, 45-53 doi:10.1007/s00280-008-0706-x.
88. Reddy, V., Valasinas, A., Sarkar, A., Basu, H., Marton, L. and Frydman, B. (1998) Conformationally restricted analogues of 1N, 12N-bisethylspermine: synthesis and growth inhibitory effects on human tumor cell lines. J. Med. Chem. 41, 4723-4732 doi:10.1021/jm980172v.
89. Valasinas, A., Sarkar, A., Reddy, V.K., Marton, L.J., Basu, H.S. and Frydman, B. (2001) Conformationally restricted analogues of 1N, 14N-bisethylhomospermine (BE-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cells. J. Med. Chem. 44, 390-403 doi:10.1021/jm000309t.
90. Huang, Y., Hager, E.R., Phillips, D.L., Hacker, A., Frydman, B., Valasinas, A.L. et al. (2002) Conformationally constrained polyamine analogues and oligoamines inhibit growth and induce apoptosis in human breast cancer cells. Proc. Am. Assoc. Cancer Res. 43, 90
91. Weisell, J., Hyvonen, M.T., Alhonen, L., Vepsalainen, J., Keinanen, T.A. and Khomutov, A.R. (2014) Charge deficient analogues of the natural polyamines. Curr. Pharm. Des. 20, 262-277 doi:10.2174/13816128113199990037.
92. Keinänen, T.A., Hyvönen, M.T., Alhonen, L., Vepsäläainen, J. and Khomutov, A.R. (2014) Selective regulation of polyamine metabolism with methylated polyamine analogues. Amino Acids 46, 605-620 doi:10.1007/s00726-013-1587-9.
93. Xie, S., Wang, J., Zhang, Y. and Wang, C. (2010) Antitumor conjugates with polyamine vectors and their molecular mechanisms. Expert Opin. Drug Deliv. 7, 1049-1061 doi:10.1517/17425247.2010.504205.
94. Annereau, J.-P., Brel, V., Dumontet, C., Guminski, Y., Imbert, T., Broussas, M. et al. (2010) A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment. Leuk. Res. 34, 1383-1389 doi:10.1016/j.leukres.2009.12.021.
95. Li, M., Li, Q., Zhang, Y.-H., Tian, Z.-Y., Ma, H.-X., Zhao, J. et al. (2013) Antitumor effects and preliminary systemic toxicity of ANISpm in vivo and in vitro. Anticancer Drugs 24, 32-42 doi:10.1097/CAD.0b013e328359affd.
96. Traquete, R., Ghani, R.A., Phanstiel, O. and Wallace, H.M. (2013) Ant 4, 4, a polyamine-Anthracene conjugate, induces cell death and recovery in human promyelogenous leukemia cells (HL-60). Amino Acids 44, 1193-1203 doi:10.1007/s00726-012-1452-2.
97. Phanstiel, O.T., Kaur, N. and Delcros, J.G. (2007) Structure-Activity investigations of polyamine-Anthracene conjugates and their uptake via the polyamine transporter. Amino Acids 33, 305-313 doi:10.1007/s00726-007-0527-y.
98. Vourtsis, D., Lamprou, M., Sadikoglou, E., Giannou, A., Theodorakopoulou, O., Sarrou, E. et al. (2013) Effect of an all-Trans-retinoic acid conjugate with spermine on viability of human prostate cancer and endothelial cells in vitro and angiogenesis in vivo. Eur. J. Pharmacol. 698, 122-130 doi:10.1016/j.ejphar.2012.11.007.
99. Huang, Y., Marton, L.J., Woster, P.M. and Casero, R.A. (2009) Polyamine analogues targeting epigenetic gene regulation. Essays Biochem. 46, 95-110 doi:10.1042/bse0460007.
100. Varghese, S., Senanayake, T., Murray-Stewart, T., Doering, K., Fraser, A., Casero Jr, R.A. et al. (2008) Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors. J. Med. Chem. 51, 2447-2456 doi:10.1021/jm701384x.
101. Varghese, S., Gupta, D., Baran, T., Jiemjit, A., Gore, S.D., Casero Jr, R.A. et al. (2005) Alkyl-substituted polyaminohydroxamic acids: A novel class of targeted histone deacetylase inhibitors. J. Med. Chem. 48, 6350-6365 doi:10.1021/jm0505009.
102. Huang, Y., Stewart, T.M., Wu, Y., Baylin, S.B., Marton, L.J., Perkins, B. et al. (2009) Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes. Clin. Cancer Res. 15, 7217-7228 doi:10.1158/1078-0432.CCR-09-1293.
103. Huang, Y., Greene, E., Murray Stewart, T., Goodwin, A.C., Baylin, S.B., Woster, P.M. et al. (2007) Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc. Natl Acad. Sci. USA 104, 8023-8028 doi:10.1073/pnas.0700720104.
104. Nowotarski, S.L., Pachaiyappan, B., Holshouser, S.L., Kutz, C.J., Li, Y., Huang, Y. et al. (2015) Structure-Activity study for (bis)ureidopropyl-And (bis) thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures. Bioorg. Med. Chem. 23, 1601-1612doi:10.1016/j.bmc.2015.01.049.
105. Sharma, S.K., Hazeldine, S., Crowley, M.L., Hanson, A., Beattie, R., Varghese, S. et al. (2012) Polyamine-based small molecule epigenetic modulators. Med. Chem. Commun. 3, 14-21 doi:10.1039/C1MD00220A.
106. Schenk, T., Chen, W.C., Göllner, S., Howell, L., Jin, L., Hebestreit, K. et al. (2012) Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-Trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat. Med. 18, 605-611 doi:10.1038/nm.2661.
107. Sharma, S.K., Wu, Y., Steinbergs, N., Crowley, M.L., Hanson, A.S., Casero, R.A. et al. (2010) (Bis)urea and (Bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators. J. Med. Chem. 53, 5197-5212 doi:10.1021/jm100217a.
108. Loiseau, P.M., Chauffert, O. and Czok, M. (1997) Effect of chronic trypanosomiasis on the bioavailability of alpha-difluoromethylornithine (DFMO) after oral administration: pharmacokinetics study on DFMO plasma levels in infected and noninfected mice using a high-performance liquid chromatography assay. Parasitol. Res. 83, 386-389 doi:10.1007/s004360050268.
109. McCann, P.P., Bitonti, A.J., Bacchi, C.J. and Clarkson Jr, A.B. (1987) Use of difluoromethylornithine (DFMO, eflornithine) for late-stage African trypanosomiasis. Trans. R. Soc. Trop. Med. Hyg. 81, 701-702 doi:10.1016/0035-9203(87)90465-2.
110. Nilsson, J.A., Keller, U.B., Baudino, T.A., Yang, C., Norton, S., Old, J.A. et al. (2005) Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. Cancer Cell 7, 433-444 doi:10.1016/j.ccr.2005.03.036.
111. O'Brien, T.G., Megosh, L.C., Gilliard, G. and Soler, A.P. (1997) Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res. 57, 2630-2637 PMID:9205069.
112. Guo, Y., Zhao, J., Sawicki, J., Peralta Soler, A. and O'Brien, T.G. (1999) Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression. Mol. Carcinog. 26, 32-36 doi:10.1002/(SICI)1098-2744(199909)26:1<32::AID-MC4>3.0.CO;2-E.
113. Chen, Y., Megosh, L.C., Gilmour, S.K., Sawicki, J.A. and O'Brien, T.G. (2000) K6/ODC transgenic mice as a sensitive model for carcinogen identification. Toxicol. Lett. 116, 27-35. doi:10.1016/S0378-4274(00)00196-X.
114. Hibshoosh, H., Johnson, M. and Weinstein, I.B. (1991) Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation. Oncogene 6, 739-743 PMID:1711188.
115. Slaga, T.J. (1984) Multistage skin carcinogenesis: A useful model for the study of the chemoprevention of cancer. Acta Pharmacol. Toxicol. 55(Suppl. 2), 107-124 PMID:6385617.
116. Malt, R.A., Kingsnorth, A.N., Lamuraglia, G.M., Lacaine, F. and Ross, J.S. (1985) Chemoprevention and chemotherapy by inhibition of ornithine decarboxylase activity and polyamine synthesis: colonic, pancreatic, mammary, and renal carcinomas. Adv. Enzyme Regul. 24, 93-102 doi:10.1016/0065-2571(85)90071-8.
117. Tempero, M.A., Nishioka, K., Knott, K. and Zetterman, R.K. (1989) Chemoprevention of mouse colon tumors with difluoromethylornithine during and after carcinogen treatment. Cancer Res. 49, 5793-5797 PMID:2507137.
118. Reddy, B.S., Nayini, J., Tokumo, K., Rigotty, J., Zang, E. and Kelloff, G. (1990) Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D, L-Alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res. 50, 2562-2568 PMID:2109653.
119. Pegg, A.E., Shantz, L.M. and Coleman, C.S. (1995) Ornithine decarboxylase as a target for chemoprevention. J. Cell Biochem. 59(Suppl. 22), 132-138 doi:10.1002/jcb.240590817.
120. Meyskens Jr, F.L. and Gerner, E.W. (1995) Development of difluoromethylornithine as a chemoprevention agent for the management of colon cancer. J. Cell Biochem. 59(Suppl. 22), 126-131 doi:10.1002/jcb.240590816.
121. Gerner, E.W. and Meyskens Jr, F.L. (2009) Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin. Cancer Res. 15, 758-761 doi:10.1158/1078-0432.CCR-08-2235.
122. Meyskens Jr, F.L., McLaren, C.E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P.M., Hawk, E. et al. (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: A randomized placebo-controlled, double-blind trial. Cancer Prev. Res. 1, 32-38 doi:10.1158/1940-6207.CAPR-08-0042.
123. Li, J., Cameron, G.A. and Wallace, H.M. (2015) Decreased sensitivity to aspirin is associated with altered polyamine metabolism in human prostate cancer cells. Amino Acids 48, 1003-1012 doi:10.1007/s00726-015-2143-6.
124. Meyskens Jr, F.L., Simoneau, A.R. and Gerner, E.W. (2014) Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine. Recent Results Cancer Res. 202, 115-120 doi:10.1007/978-3-642-45195-9-14.
125. Esmat, A.Y., Refaie, F.M., Shaheen, M.H. and Said, M.M. (2002) Chemoprevention of prostate carcinogenesis by DFMO and/or finasteride treatment in male Wistar rats. Tumori 88, 513-521 PMID:12597149.
126. Jeter, J.M., Curiel-Lewandrowski, C., Stratton, S.P., Myrdal, P.B., Warneke, J.A., Einspahr, J.G. et al. (2016) Phase IIB randomized study of topical difluoromethylornithine and topical diclofenac on sun-damaged skin of the forearm. Cancer Prev. Res. 9, 128-134 doi:10.1158/1940-6207.CAPR-15-0232.
127. Witherspoon, M., Chen, Q., Kopelovich, L., Gross, S.S. and Lipkin, S.M. (2013) Unbiased metabolite profiling indicates that a diminished thymidine pool is the underlying mechanism of colon cancer chemoprevention by alpha-difluoromethylornithine. Cancer Discov. 3, 1072-1081 doi:10.1158/2159-8290.CD-12-0305.
128. Babbar, N. and Casero Jr, R.A. (2006) Tumor necrosis factor-Alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: A potential mechanism for inflammation-induced carcinogenesis. Cancer Res. 66, 11125-11130 doi:10.1158/0008-5472.CAN-06-3174.
129. Xu, H., Chaturvedi, R., Cheng, Y., Bussiere, F.I., Asim, M., Yao, M.D. et al. (2004) Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res. 64, 8521-8525 doi:10.1158/0008-5472.CAN-04-3511.
130. Chaturvedi, R., Cheng, Y., Asim, M., Bussiere, F.I., Xu, H., Gobert, A.P. et al. (2004) Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J. Biol. Chem. 279, 40161-40173 doi:10.1074/jbc.M401370200.
131. Goodwin, A.C., Shields, C.E.D., Wu, S., Huso, D.L., Wu, X., Murray-Stewart, T.R. et al. (2011) Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc. Natl Acad. Sci. USA 108, 15354-15359 doi:10.1073/pnas.1010203108.
132. Chaturvedi, R., de Sablet, T., Asim, M., Piazuelo, M.B., Barry, D.P., Verriere, T.G. et al. (2015) Increased Helicobacter pylori-Associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase. Oncogene 34, 3429-3440 doi:10.1038/onc.2014.273.
133. Goodwin, A.C., Jadallah, S., Toubaji, A., Lecksell, K., Hicks, J.L., Kowalski, J. et al. (2008) Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues. Prostate 68, 766-772 doi:10.1002/pros.20735.
134. Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.R. et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016-1022 doi:10.1038/nm.2015.
135. Sears, C.L. (2009) Enterotoxigenic Bacteroides fragilis: A rogue among symbiotes. Clin. Microbiol. Rev. 22, 349-369 doi:10.1128/CMR.00053-08.
136. Wu, S., Morin, P.J., Maouyo, D. and Sears, C.L. (2003) Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 124, 392-400 doi:10.1053/gast.2003.50047.
137. Moser, A.R., Pitot, H.C. and Dove, W.F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324 doi:10.1126/science.2296722.
138. Su, L., Kinzler, K., Vogelstein, B., Preisinger, A., Moser, A., Luongo, C. et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670 doi:10.1126/science.1350108.
139. Johnson, C.H., Dejea, C.M., Edler, D., Hoang, L.T., Santidrian, A.F., Felding, B.H. et al. (2015) Metabolism links bacterial biofilms and colon carcinogenesis. Cell. Metab. 21, 891-897 doi:10.1016/j.cmet.2015.04.011.
140. de Sablet, T., Piazuelo, M.B., Shaffer, C.L., Schneider, B.G., Asim, M., Chaturvedi, R. et al. (2011) Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 60, 1189-1195 doi:10.1136/gut.2010.234468.
141. Khobta, A., Anderhub, S., Kitsera, N. and Epe, B. (2010) Gene silencing induced by oxidative DNA base damage: Association with local decrease of histone H4 acetylation in the promoter region. Nucleic Acids Res. 38, 4285-4295 doi:10.1093/nar/gkq170.
142. Watanabe, S., Ichimura, T., Fujita, N., Tsuruzoe, S., Ohki, I., Shirakawa, M. et al. (2003) Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin. Proc. Natl Acad. Sci. USA 100, 12859-12864 doi:10.1073/pnas.2131819100.
143. O'Hagan, H.M., Mohammad, H.P. and Baylin, S.B. (2008) Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet. 4, e1000155 doi:10.1371/journal.pgen.1000155.
144. O'Hagan, H.M., Wang, W., Sen, S., Destefano Shields, C., Lee, S.S., Zhang, Y.W. et al. (2011) Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell 20, 606-619 doi:10.1016/j.ccr.2011.09.012.
145. Hahn, M.A., Hahn, T., Lee, D.H., Esworthy, R.S., Kim, B.-W., Riggs, A.D. et al. (2008) Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 68, 10280-10289 doi:10.1158/0008-5472.CAN-08-1957.
146. Murray-Stewart, T., Sierra, J.C., Piazuelo, M.B., Mera, R.M., Chaturvedi, R., Bravo, L.E. et al. (2016) Epigenetic silencing of miR-124 prevents spermine oxidase regulation: implications for Helicobacter pylori-induced gastric cancer. Oncogene, in press doi:10.1038/onc.2016.91.
147. Cervelli, M., Salvi, D., Polticelli, F., Amendola, R. and Mariottini, P. (2013) Structure-function relationships in the evolutionary framework of spermine oxidase. J. Mol. Evol. 76, 365-370 doi:10.1007/s00239-013-9570-3.
148. Polticelli, F., Salvi, D., Mariottini, P., Amendola, R. and Cervelli, M. (2012) Molecular evolution of the polyamine oxidase gene family in Metazoa. BMC Evol. Biol. 12, 90. doi:10.1186/1471-2148-12-90.
149. Tavladoraki, P., Cervelli, M., Antonangeli, F., Minervini, G., Stano, P., Federico, R. et al. (2011) Probing mammalian spermine oxidase enzyme-substrate complex through molecular modeling, site-directed mutagenesis and biochemical characterization. Amino Acids 40, 1115-1126 doi:10.1007/s00726-010-0735-8.
150. Lakanen, J.R., Coward, J.K. and Pegg, A.E. (1992) Alpha-methyl polyamines: metabolically stable spermidine and spermine mimics capable of supporting growth in cells depleted of polyamines. J. Med. Chem. 35, 724-734.